GIP-dependent expression of hypothalamic genes

Physiological Research

Volumn 60, Issue 6, 2011, Pages 941-950

  Ambati, S ^a   Duan, J ^a   Hartzell, D L ^a   Choi, Y H ^c   Della Fera, M A ^a   Baile, C A ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c Gyeongsang National University   (South Korea)

Author keywords

GIP receptor knockout; ICV administration; Mice; mRNA expression; Rats

Indexed keywords

EID: 84856417736     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932151     Document Type: Article

References (71)

1. Abbott CR, Rossi M, Wren AM, Murphy KG, Kennedy AR, Stanley SA, Zollner AN, Morgan DG, Morgan I, Ghatei MA, Small CJ, Bloom SR: Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 142: 3457-3463, 2001.
2. Aja S, Schwartz GJ, Kuhar MJ, Moran TH: Intracerebroventricular CART peptide reduces rat ingestive behavior and alters licking microstructure. Am J Physiol Regul Integr Comp Physiol 280: R1613-R1619, 2001.
3. Altarejos JY, Montminy M: CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 12: 141-151, 2011.
4. Ambati S, Duan J, Choi YH, Hartzell DL, Della-Fera MA, Baile CA: ICV vs. VMH injection of leptin: Comparative effects on hypothalamic gene expression. Behav Brain Res 196: 279-285, 2009.
5. Ambati S, Duan J, Duff E, Choi YH, Hartzell DL, Della-Fera MA, Baile CA: Gene expression in arcuate nucleus of rats treated with leptin or ciliary neurotrophic factor. Biofactors 31: 133-144, 2007.
6. Asakawa A, Inui A, Yuzuriha H, Nagata T, Kaga T, Ueno N, Fujino MA, Kasuga M: Cocaineamphetamine- regulated transcript influences energy metabolism, anxiety and gastric emptying in mice. Horm Metab Res 33: 554-558, 2001.
7. Auernhammer CJ, Bousquet C, Chesnokova V, Melmed S: SOCS proteins: modulators of neuroimmunoendocrine functions. Impact on corticotroph LIF signaling. Ann N Y Acad Sci 917: 658-664, 2000.
8. Bale TL, Davis AM, Auger AP, Dorsa DM, Mccarthy MM: CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 21: 2546-2552, 2001.
9. Boston BA: Pro-opiomelanocortin and weight regulation: from mice to men. J Pediatr Endocrinol Metab 14 (Suppl 6): 1409-1416, 2001.
10. Bray GA: Afferent signals regulating food intake. Proc Nutr Soc 59: 373-384, 2000.
11. Buchan AM, Polak JM, Capella C, Solcia E, Pearse AG: Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56: 37-44, 1978.
12. Carlezon WA Jr, Duman RS, Nestler EJ: The many faces of CREB. Trends Neurosci 28: 436-445, 2005.
13. Carvalheira JB, Siloto RM, Ignacchitti I, Brenelli SL, Carvalho CR, Leite A, Velloso LA, Gontijo JA, Saad MJ: Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett 500: 119-124, 2001.
14. Cheng CY, Chu JY, Chow BK: Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system. Neuropsychopharmacology 36: 459-471, 2011.
15. Choi YH, Li C, Page K, Westby A, Della-Fera MA, Lin J, Hartzell DL, Baile CA: Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis. Physiol Behav 79: 795-801, 2003.
16. Coogan AN, Piggins HD: MAP kinases in the mammalian circadian system-key regulators of clock function. J Neurochem 90: 769-775, 2004.
17. Couceyro PR, Koylu EO, Kuhar MJ: Further studies on the anatomical distribution of CART by in situ hybridization. J Chem Neuroanat 12: 229-241, 1997.
18. Cui Y, Huang L, Elefteriou F, Yang G, Shelton JM, Giles JE, Oz OK, Pourbahrami T, Lu CY, Richardson JA, Karsenty G, Li C: Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol 24: 258-269, 2004.
19. Dandoy-Dron F, Itier JM, Monthioux E, Bucchini D, Jami J: Tissue-specific expression of the rat insulin 1 gene in vivo requires both the enhancer and promoter regions. Differentiation 58: 291-295, 1995.
20. Ding KH, Shi XM, Zhong Q, Kang B, Xie D, Bollag WB, Bollag RJ, Hill W, Washington W, Mi QS, Insogna K, Chutkan N, Hamrick M, Isales CM: Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res 23: 536-543, 2008.
21. Ding KH, Zhong Q, Xie D, Chen HX, Della-Fera MA, Bollag RJ, Bollag WB, Gujral R, Kang B, Sridhar S, Baile C, Curl W, Isales CM: Effects of glucose-dependent insulinotropic peptide on behavior. Peptides 27: 2750-2755, 2006.
22. Duman CH, Duman RS: Neurobiology and treatment of anxiety: signal transduction and neural plasticity. Handb Exp Pharmacol 169: 305-334, 2005.
23. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G: Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520, 2005.
24. Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, Nelson FK, Sayward F, Luscombe NM, Miller P, Gerstein M, Weissman S, Snyder M: CREB binds to multiple loci on human chromosome 22. Mol Cell Biol 24: 3804-3814, 2004.
25. Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, Bechmann I, Leranth C, Toran-Allerand D, Priest CA, Roberts JL, Gao XB, Mobbs C, Shulman GI, Diano S, Horvath TL: Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med 13: 89-94, 2007.
26. Georgescu D, Sears RM, Hommel JD, Barrot M, Bolanos CA, Marsh DJ, Bednarek MA, Bibb JA, Maratos-Flier E, Nestler EJ, Dileone RJ: The hypothalamic neuropeptide melaninconcentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci 25: 2933-2940, 2005.
27. Hauner H, Glatting G, Kaminska D, Pfeiffer EF: Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab 32: 282-288, 1988.
28. Hegyi K, Fulop K, Kovacs K, Toth S, Falus A: Leptin-induced signal transduction pathways. Cell Biol Int 28: 159-169, 2004.
29. Holst JJ: On the physiology of GIP and GLP-1. Horm Metab Res 36: 747-754, 2004.
30. Hommel JD, Trinko R, Sears RM, Georgescu D, Liu ZW, Gao XB, Thurmon JJ, Marinelli M, Dileone RJ: Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51: 801-810, 2006.
31. Hubschle T, Thom E, Watson A, Roth J, Klaus S, Meyerhof W: Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci 21: 2413-2424, 2001.
32. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS: Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 88: 10931-10935, 1991.
33. Kalra SP, Kalra PS: Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 22: 49-56, 2003.
34. Kaplan AM, Vigna SR: Gastric inhibitory polypeptide (GIP) binding sites in rat brain. Peptides 15: 297-302, 1994.
35. Kieffer TJ: GIP or not GIP? That is the question. Trends in pharmacological sciences 24: 110-112, 2003.
36. Kong WM, Stanley S, Gardiner J, Abbott C, Murphy K, Seth A, Connoley I, Ghatei M, Stephens D, Bloom S: A role for arcuate cocaine and amphetamine-regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J 17: 1688-1690, 2003.
37. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S: Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393: 72-76, 1998.
38. Lambert PD, Anderson KD, Sleeman MW, Wong V, Tan J, Hijarunguru A, Corcoran TL, Murray JD, Thabet KE, Yancopoulos GD, Wiegand SJ: Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci USA 98: 4652-4657, 2001.
39. Landgraf R: The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5: 167-179, 2006.
40. Lee AK, Mojtahed-Jaberi M, Kyriakou T, Aldecoa-Otalora Astarloa E, Arno M, Marshall NJ, Brain SD, O'Dell SD: Effect of high-fat feeding on expression of genes controlling availability of dopamine in mouse hypothalamus. Nutrition 26: 411-422, 2010.
41. Li G, Mobbs CV, Scarpace PJ: Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats. Diabetes 52: 1951-1957, 2003.
42. Ma'ayan A, Jenkins SL, Barash A, Iyengar R: Neuro2A differentiation by Galphai/o pathway. Sci Signal 2: cm1, 2009.
43. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y: Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8: 738-742, 2002.
44. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y: Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96: 14843-14847, 1999.
45. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F: Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45: 257-261, 1996.
46. Morris DL, Rui L: Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297: E1247-E1259, 2009.
47. Nyberg J, Anderson MF, Meister B, Alborn AM, Strom AK, Brederlau A, Illerskog AC, Nilsson O, Kieffer TJ, Hietala MA, Ricksten A, Eriksson PS: Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation. J Neurosci 25: 1816-1825, 2005.
48. Ohinata K, Takagi K, Biyajima K, Fujiwara Y, Fukumoto S, Eguchi N, Urade Y, Asakawa A, Fujimiya M, Inui A, Yoshikawa M: Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice. FEBS Lett 582: 679-684, 2008.
49. Pandey SC: Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 24: 456-460, 2003.
50. Qing K, Chen Y: Central CART gene delivery by recombinant AAV vector attenuates body weight gain in dietinduced- obese rats. Regul Pept 140: 21-26, 2007.
51. Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG: Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 114: 652-658, 2004.
52. Rodriguez A, Ferrer I: Expression of transcription factors CREB and c-Fos in the brains of terminal Creutzfeldt- Jakob disease cases. Neurosci Lett 421: 10-15, 2007.
53. Sabatier N, Rowe I, Leng G: Central release of oxytocin and the ventromedial hypothalamus. Biochem Soc Trans 35: 1247-1251, 2007.
54. Sandberg EM, Ma X, Vonderlinden D, Godeny MD, Sayeski PP: Jak2 tyrosine kinase mediates angiotensin II-dependent inactivation of ERK2 via induction of mitogen-activated protein kinase phosphatase 1. J Biol Chem 279: 1956-1967, 2004.
55. Sano S, Itami S, Takeda K, Tarutani M, Yamaguchi Y, Miura H, Yoshikawa K, Akira S, Takeda J: Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 18: 4657-4668, 1999.
56. Sherwood NM, Krueckl SL, Mcrory JE: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21: 619-670, 2000.
57. Smith KL, Gardiner JV, Ward HL, Kong WM, Murphy KG, Martin NM, Ghatei MA, Bloom SR: Overexpression of CART in the PVN increases food intake and weight gain in rats. Obesity (Silver Spring) 16: 2239-2244, 2008.
58. Sondhi S, Castellano JM, Chong VZ, Rogoza RM, Skoblenick KJ, Dyck BA, Gabriele J, Thomas N, Ki K, Pristupa ZB, Singh AN, Maccrimmon D, Voruganti P, Foster J, Mishra RK: cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Pharmacogenomics J 6: 131-140, 2006.
59. Stanley SA, Small CJ, Murphy KG, Rayes E, Abbott CR, Seal LJ, Morgan DG, Sunter D, Dakin CL, Kim MS, Hunter R, Kuhar M, Ghatei MA, Bloom SR: Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 893: 186-194, 2001.
60. Tian DR, Li XD, Shi YS, Wan Y, Wang XM, Chang JK, Yang J, Han JS: Changes of hypothalamic alpha-MSH and CART peptide expression in diet-induced obese rats. Peptides 25: 2147-2153, 2004.
61. Turnbull AV, Rivier C: Corticotropin-releasing factor, vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology 137: 455-463, 1996.
62. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI: Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861-2870, 1993.
63. Veenema AH, Neumann ID: Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog Brain Res 170: 261-276, 2008.
64. Villanueva EC, Myers MG Jr: Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes (Lond) 32 (Suppl 7): S8-S12, 2008.
65. Wasada T, Harris V, Kawai K, Howard B, Uger RH: Effects of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs. J Clin Invest 68: 1106-1107, 1981.
66. Wideman RD, Kieffer TJ: Glucose-dependent insulinotropic polypeptide as a regulator of beta cell function and fate. Horm Metab Res 36: 782-786, 2004.
67. Windpassinger C, Kroisel PM, Wagner K, Petek E: The human gamma-aminobutyric acid A receptor delta (GABRD) gene: molecular characterisation and tissue-specific expression. Gene 292: 25-31, 2002.
68. Wortley KE, Chang GQ, Davydova Z, Fried SK, Leibowitz SF: Cocaine- and amphetamine-regulated transcript in the arcuate nucleus stimulates lipid metabolism to control body fat accrual on a high-fat diet. Regul Pept 117: 89-99, 2004.
69. Yip RG, Wolfe MM: GIP biology and fat metabolism. Life Sci 66: 91-103, 2000.
70. Zachariou V, Georgescu D, Kansal L, Merriam P, Picciotto MR: Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism. J Neurochem 76: 191-200, 2001.
71. Zhao AZ, Huan JN, Gupta S, Pal R, Sahu A: A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat Neurosci 5: 727-728, 2002.